loadpatents
Patent applications and USPTO patent grants for Dudley; David T..The latest application filed is for "materials and methods for eliciting targeted antibody responses in vivo".
Patent | Date |
---|---|
Materials and Methods for Eliciting Targeted Antibody Responses In Vivo App 20200254077 - Kind Code | 2020-08-13 |
Materials and Methods for Eliciting Targeted Antibody Responses In Vivo App 20180228880 - Weiss; Stephen J. ;   et al. | 2018-08-16 |
Materials and Methods for Eliciting Targeted Antibody Responses In Vivo App 20150174224 - Weiss; Stephen J. ;   et al. | 2015-06-25 |
Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation Grant 8,975,029 - Weiss , et al. March 10, 2 | 2015-03-10 |
Integrin Alpha-2 Binding Agents and Use Thereof to Inhibit Cancer Cell Proliferation App 20120294865 - Weiss; Stephen J. ;   et al. | 2012-11-22 |
Imidazo-pyridine angiotensin II antagonists used to treat memory loss Grant 5,444,069 - Dudley , et al. August 22, 1 | 1995-08-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.